<DOC>
	<DOCNO>NCT00568035</DOCNO>
	<brief_summary>The purpose study determine whether QR-333 safe effective treatment diabetic neuropathy compare placebo .</brief_summary>
	<brief_title>Safety Efficacy Study QR-333 Patient 's With Symptomatic Diabetic Neuropathy</brief_title>
	<detailed_description>Diabetic neuropathy among common complication diabetes , result pain numbness , affect patient sleep , function well-being . The pain often accompany unpleasant sensation describe buzz , cramp-like , burning , jolt . The pain usually symmetrical occurs upper low extremity follow `` glove stocking '' distribution . To date fully effective treatment diabetic neuropathy . Therapy tailor individually accord subject complaint may select category include Non-steroidal anti-inflammatory drug ( NSAIDs ) adjuvant analgesic ( include tricyclic antidepressant anticonvulsant ) . The clinical trial conduct determine safety efficacy QR-333 treatment diabetic neuropathy compare placebo .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>diagnosis diabetic neuropathy must pain daily low limb due diabetic polyneuropathy least 3 month prior enrollment must willing comply study direction , write information diary ( pain medication take ) , read comprehend write instruction , complete questionnaire , ability apply cream direct uncontrolled pain persist &gt; 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>diabetic</keyword>
	<keyword>peripheral</keyword>
	<keyword>neuropathy</keyword>
</DOC>